CARBON: UAB Cardiovascular Research Biobank
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Sep 23, 2021
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The CARBON study, or UAB Cardiovascular Research Biobank, is focused on understanding various heart-related conditions, such as high blood pressure, diabetes, and obesity. This project aims to collect and store biological samples, like DNA, along with health and personal information from many participants over time. This valuable information will help researchers in the future to develop better treatments and understand cardiovascular diseases more deeply.
To participate, individuals must be at least 18 years old. However, people who work or study at the UAB Cardiovascular Disease Division cannot join, and pregnant women or those who could become pregnant without using effective birth control are also excluded. If you decide to take part, you can expect to provide some health information and biological samples, contributing to important medical research that could help many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age more than or equal to 18
- Exclusion Criteria:
- • Age \<18, at screening
- • Employees or students associated with the Division of Cardiovascular Disease at UAB will not be recruited due to their vulnerable status and susceptibility to coercion.
- • Women who are pregnant or who can become pregnant and not practicing an acceptable method of birth control.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Pankaj Arora, MD, FAHA
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials